Science news from the best sources

Engineered immunosuppressive dendritic cells protect against cardiac remodelling

Xiaoying Li

Nature, Published online: 08 April 2026; doi:10.1038/s41586-026-10346-5

Lesion-targeted immune modulation is a feasible strategy to control cardiac fibrosis, and engineered dendritic cells are a promising therapeutic platform for treating cardiac remodelling and heart failure. Read More Nature

Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.